Fidaxomicin for treatment of clostridium difficile-associated diarrhea and its potential role for prophylaxis

ISSN： 1465-6566

Source： Expert Opinion on Pharmacotherapy, Vol.14, Iss.11, 2013-08, pp. : 1529-1536

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Fidaxomicin: a guide to its use in Clostridium difficile infection

By Scott Lesley J. Lyseng-Williamson Katherine A. Duggan Sean T.

Drugs & Therapy Perspectives, Vol. 28, Iss. 6, 2012-06 ,pp. : 1-5

Adis International

Access to resources Recommend Favorite

Fidaxomicin: In Clostridium difficile Infection

By Duggan Sean T.

Drugs, Vol. 71, Iss. 18, 2011-12 ,pp. : 2445-2456

Adis International

Access to resources Recommend Favorite

Fidaxomicin (OPT-80) for the treatment of Clostridium difficile infection

By Miller Mark

Expert Opinion on Pharmacotherapy, Vol. 11, Iss. 9, 2010-06 ,pp. : 1569-1578

Informa Healthcare

Access to resources Recommend Favorite

Clostridium difficile-Associated Disease: Changing Epidemiology and Implications for Management

By Owens Robert C.

Drugs, Vol. 67, Iss. 4, 2007-01 ,pp. : 487-502

Adis International

Access to resources Recommend Favorite

Methotrexate: Clostridium difficile-associated colitis leading to reactive arthritis: case report

Reactions Weekly, Vol. 1, Iss. 1360, 2011-01 ,pp. : 26-27

Adis International

Access to resources Recommend Favorite